Medicenna Therapeutics Corp.
MDNAF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807983
No open-market purchases or sales by Medicenna Therapeutics Corp. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Medicenna Therapeutics Corp. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −1 vs. Q1 2022
- Shares held
- 4.50M
- +212.4K (+5.0%) vs. Q1 2022
- Total value
- $5.41M
- −$52.0K (−1.0%) vs. Q1 2022
- New holders
- 3
- 4 more added
- Sold out
- 4
- 3 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDNAF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $200.4K |
| Q3 2024 | 1 | $175.0K |
| Q2 2024 | 1 | $145.0K |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $40.9K |
| Q3 2023 | 26 | $2.45M |
| Q2 2023 | 28 | $4.75M |
| Q1 2023 | 28 | $6.25M |
| Q4 2022 | 28 | $4.75M |
| Q3 2022 | 29 | $9.67M |
| Q2 2022 | 19 | $5.41M |
| Q1 2022 | 20 | $5.47M |
| Q4 2021 | 23 | $7.42M |
| Q3 2021 | 25 | $8.66M |
| Q2 2021 | 26 | $15.4M |
| Q1 2021 | 31 | $22.9M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Medicenna Therapeutics Corp.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 2,272,700 | $2.65M | 1.10% | 00.0% | Unchanged |
| Worth Venture Partners, LLC | 571,489 | $846.0K | 0.51% | 00.0% | Unchanged |
| Verition Fund Management LLC | 539,051 | $631.0K | 0.01% | 00.0% | Unchanged |
| Sigma Planning Corp | 252,050 | $292.0K | 0.01% | +51,750+25.8% | Added |
| Morgan Stanley | 201,800 | $234.0K | 0.00% | +197,981+5,184.1% | Added |
| ACT Capital Management, LLC | 149,070 | $173.0K | 0.24% | −3,430−2.2% | Reduced |
| Tocqueville Asset Management L.P. | 113,000 | $132.0K | 0.00% | +25,000+28.4% | Added |
| Letko, Brosseau & Associates Inc | 100,000 | $116.0K | 0.00% | 00.0% | Unchanged |
| McKinley Carter Wealth Services, Inc. | 79,259 | $92.0K | 0.01% | 00.0% | Unchanged |
| Rathbone Brothers plc | 40,000 | $46.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 34,144 | $39.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 32,100 | $37.0K | 0.00% | −7,600−19.1% | Reduced |
| Toronto Dominion Bank | 29,103 | $33.0K | 0.00% | +27,228+1,452.2% | Added |
| Advisor Group Holdings, Inc. | 22,176 | $25.0K | 0.00% | 00.0% | Unchanged |
| Great Valley Advisor Group, Inc. | 19,500 | $23.0K | 0.00% | +19,500 | New |
| Patriot Financial Group Insurance Agency, LLC | 17,900 | $21.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 16,368 | $19.0K | 0.00% | +16,368 | New |
| Royal Bank of Canada | 5,325 | $6.00K | 0.00% | −6,506−55.0% | Reduced |
| Tower Research Capital LLC (TRC) | 1,464 | $2.00K | 0.00% | +1,464 | New |
| Intact Investment Management Inc. | 0 | $0 | 0.00% | −73,900−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −20,861−100.0% | Sold out |
| Newman Dignan & Sheerar, Inc. | 0 | $0 | 0.00% | −12,915−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −1,666−100.0% | Sold out |